Improvement of Antibody Responses by HIV Envelope DNA and Protein Co-Immunization

BACKGROUND: Developing HIV Envelope (Env) vaccine components that elicit durable and protective antibody responses is an urgent priority, given the results from the RV144 trial. Optimization of both the immunogens and vaccination strategies will be needed to generate potent, durable antibodies. Due...

Full description

Saved in:
Bibliographic Details
Main Authors: Pissani, Franco, Malherbe, Delphine C., Schuman, Jason T., Robins, Harlan, Park, Byung S., Krebs, Shelly J., Barnett, Susan W., Haigwood, Nancy L.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3926420/
https://ncbi.nlm.nih.gov/pubmed/24280279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.11.022
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items